Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | P2RY1 | P47900 | 3/20 | 0.31 |
| ▸ | C1R | P00736 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
| ▸ | RPS6KA2 | Q15349 | 1/20 | 0.30 |
| ▸ | P2RY14 | Q15391 | 1/20 | 0.30 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20172843 | 0.91 | HSD11B1 (0.36) | HTR6ALDH1A1L3MBTL1HSD11B1C1R | |
| SCHEMBL20650461 | 0.87 | P2RY1 (0.31) | ALDH1A1L3MBTL1HSD11B1P2RY1C1R | |
| SCHEMBL20172815 | 0.85 | S1PR1 (0.33) | HTR6ALDH1A1L3MBTL1C1REPHX2 | |
| SCHEMBL20172808 | 0.85 | L3MBTL1 (0.32) | HTR6ALDH1A1L3MBTL1C1REPHX2 | |
| SCHEMBL21021477 | 0.84 | — | — | |
| SCHEMBL20172792 | 0.84 | MAOA (0.39) | HTR6ALDH1A1L3MBTL1C1REPHX2 | |
| SCHEMBL20172828 | 0.83 | ACP1 (0.33) | — | |
| SCHEMBL20172864 | 0.83 | EPHX2 (0.33) | ALDH1A1L3MBTL1C1REPHX2RPS6KA2 | |
| SCHEMBL20172831 | 0.83 | KIF11 (0.35) | ALDH1A1 | |
| SCHEMBL21020437 | 0.82 | SLC6A3 (0.36) | HTR6ALDH1A1L3MBTL1C1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10651411-B2 | Compound and organic light emitting device containing same | LG CHEM, LTD. (KR) | 2020-05-12 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | LG CHEM, LTD. (KR) | 2018-05-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180145272-A1 | COMPOUND AND ORGANIC LIGHT EMITTING DEVICE CONTAINING SAME | CRY1, CRY2, OR10J3 | HTR6 2028/4885ALDH1A1 87/4885L3MBTL1 349/4885 |
| US-10651411-B2 | Compound and organic light emitting device containing same | CRY1, CRY2, OR10J3 | HTR6 2028/4885ALDH1A1 87/4885L3MBTL1 349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.